These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22002576)

  • 1. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
    Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
    Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker.
    Escobar-Hoyos LF; Yang J; Zhu J; Cavallo JA; Zhai H; Burke S; Koller A; Chen EI; Shroyer KR
    Mod Pathol; 2014 Apr; 27(4):621-30. PubMed ID: 24051697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.
    Dourado MR; de Oliveira CE; Sawazaki-Calone I; Sundquist E; Coletta RD; Salo T
    J Oral Pathol Med; 2018 Feb; 47(2):121-127. PubMed ID: 29052912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
    Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
    J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
    Kerdpon D; Rich AM; Reade PC
    Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
    Hasan R; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
    BMC Cancer; 2014 Jan; 14():2. PubMed ID: 24383423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma.
    Carinci F; Stabellini G; Calvitti M; Pelucchi S; Targa L; Farina A; Pezzetti F; Pastore A
    J Craniofac Surg; 2002 Jan; 13(1):85-9. PubMed ID: 11887001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
    Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
    Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
    Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
    Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.